Health · 1 sources covering this

STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials

In this edition of STAT's AI Prognosis: A conversation with Insitro CEO Daphne Koller on artificial intelligence in drug discovery, and other health AI news.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·1h ago
STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials
In this edition of STAT's AI Prognosis: A conversation with Insitro CEO Daphne Koller on artificial intelligence in drug discovery, and other health AI news.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/f791a475837ffed6e375437c6c2516a5da8e33ff"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: AI biotech Insitro&#8217;s Daphne Koller on how to speed up clinical trials"></iframe>

STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials

How 1 sources are covering this

STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials

More from Health

STAT+: FDA approves new pancreatic cancer drug expected to usher in new era of treatment

STAT+: Key data on a new class of cardio drugs are coming

Even at big companies, health care costs are increasing

STAT+: Pharmalittle: We’re reading about a GSK shingles shot, U.S. employers dropping GLP-1 coverage, and more

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: AI biotech Insitro&#8217;s Daphne Koller on how to speed up clinical trials

More from Health

STAT+: FDA approves new pancreatic cancer drug expected to usher in new era of treatment

STAT+: Key data on a new class of cardio drugs are coming

Even at big companies, health care costs are increasing

STAT+: Pharmalittle: We&#8217;re reading about a GSK shingles shot, U.S. employers dropping GLP-1 coverage, and more

Reader

Trust & legal

Across the network

STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials

STAT+: Pharmalittle: We’re reading about a GSK shingles shot, U.S. employers dropping GLP-1 coverage, and more